PMDA — authorised 20 January 2022
- Marketing authorisation holder: AMICUS THERAPEUTICS, INC.
- Status: approved
🇯🇵 Mepsevii in Japan
PMDA authorised Mepsevii on 20 January 2022
Marketing authorisation
Mepsevii in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in Japan
Frequently asked questions
Is Mepsevii approved in Japan?
Yes. PMDA authorised it on 20 January 2022.
Who is the marketing authorisation holder for Mepsevii in Japan?
AMICUS THERAPEUTICS, INC. holds the Japanese marketing authorisation.